Implantica AG
Implantica AG engages in the research and distribution of medical implants in Switzerland. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipel… Read more
Implantica AG (IMP-A-SDB) - Total Assets
Latest total assets as of September 2025: Skr92.28 Million SEK
Based on the latest financial reports, Implantica AG (IMP-A-SDB) holds total assets worth Skr92.28 Million SEK as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Implantica AG - Total Assets Trend (2017–2024)
This chart illustrates how Implantica AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Implantica AG - Asset Composition Analysis
Current Asset Composition (December 2024)
Implantica AG's total assets of Skr92.28 Million consist of 64.4% current assets and 35.6% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 62.0% |
| Accounts Receivable | Skr589.00K | 0.6% |
| Inventory | Skr226.00K | 0.2% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr68.00K | 0.1% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Implantica AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Implantica AG's current assets represent 64.4% of total assets in 2024, an increase from 2.4% in 2017.
- Cash Position: Cash and equivalents constituted 62.0% of total assets in 2024, up from 0.9% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 88.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 0.6% of total assets.
Implantica AG Competitors by Total Assets
Key competitors of Implantica AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Implantica AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Implantica AG generates 0.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Implantica AG is currently not profitable relative to its asset base.
Implantica AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 23.97 | 22.45 | 63.69 |
| Quick Ratio | 23.86 | 22.39 | 63.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr54.10 Million | Skr 68.62 Million | Skr 96.48 Million |
Implantica AG - Advanced Valuation Insights
This section examines the relationship between Implantica AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | -19.9% |
| Total Assets | Skr104.08 Million |
| Market Capitalization | $29.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values Implantica AG's assets below their book value (0.29 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Implantica AG's assets decreased by 19.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Implantica AG (2017–2024)
The table below shows the annual total assets of Implantica AG from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr104.08 Million | -19.91% |
| 2023-12-31 | Skr129.95 Million | -12.44% |
| 2022-12-31 | Skr148.41 Million | -9.03% |
| 2021-12-31 | Skr163.13 Million | +39.88% |
| 2020-12-31 | Skr116.62 Million | +492.73% |
| 2019-12-31 | Skr19.68 Million | +6.60% |
| 2018-12-31 | Skr18.46 Million | +38.16% |
| 2017-12-31 | Skr13.36 Million | -- |